Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoh Iwasa

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Hepatology International|December 8, 2022
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter studyMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
BMJ Open|November 24, 2024
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocolMichihiro Iwaki, Takashi Kobayashi, Asako Nogami, et al.
Journal of Gastroenterology|March 7, 2025
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide surveyTakao Miwa, Mio Tsuruoka, Hajime Ueda, et al.
Journal of Gastroenterology|May 10, 2024
ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosisMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2021
Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosisMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
Infectious Diseases and Therapy|September 8, 2020
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter StudyMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Hepatology International|December 8, 2022
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter studyMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
BMJ Open|November 24, 2024
Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocolMichihiro Iwaki, Takashi Kobayashi, Asako Nogami, et al.
Journal of Gastroenterology|March 7, 2025
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide surveyTakao Miwa, Mio Tsuruoka, Hajime Ueda, et al.
Journal of Gastroenterology|May 10, 2024
ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosisMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2021
Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosisMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
Infectious Diseases and Therapy|September 8, 2020
Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter StudyMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.
Pageof 13